Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibroma × Talaporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Liver Neoplasms 5 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 2 Neurofibroma 1 Neoplasm Recurrence, Local 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

mirdametinib 2 tipifarnib 1 talimogene laherparepvec 1 peginterferon alfa-2b 1 nilotinib 1 binimetinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Temozolomide 1 Talaporfin 1 Sirolimus 1 Restraint, Physical 1 Ranibizumab 1 Radiosurgery 1 Photochemotherapy 1 Neurofibromin 1 1 Mn-PyC3A 1 Everolimus 1 Elasticity Imaging Techniques 1 Deoxycholic Acid 1 Cryotherapy 1 Celecoxib 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00716469 2015-04-15

PDT

Children's Hospital of Philadelphia

Phase 1 Terminated

Neurofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡